DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,626,087 | -18.8% | 14,615 | -21.4% | 0.18% | -14.1% |
| Q2 2023 | $4,463,828 | +107.4% | 18,599 | +117.8% | 0.20% | +84.7% |
| Q1 2023 | $2,152,651 | -7.1% | 8,541 | -2.2% | 0.11% | -10.5% |
| Q4 2022 | $2,316,851 | -1.4% | 8,729 | -4.1% | 0.12% | -12.7% |
| Q3 2022 | $2,350,000 | +14.1% | 9,099 | +12.0% | 0.14% | +22.4% |
| Q2 2022 | $2,060,000 | -15.2% | 8,126 | -1.8% | 0.12% | -4.9% |
| Q1 2022 | $2,428,000 | -14.6% | 8,278 | -4.2% | 0.12% | -11.6% |
| Q4 2021 | $2,843,000 | +4.9% | 8,641 | -3.0% | 0.14% | +16.9% |
| Q3 2021 | $2,711,000 | -5.7% | 8,904 | -16.9% | 0.12% | -23.9% |
| Q2 2021 | $2,875,000 | +23.0% | 10,714 | +3.2% | 0.16% | +12.3% |
| Q1 2021 | $2,337,000 | +0.6% | 10,385 | -0.7% | 0.14% | -13.2% |
| Q4 2020 | $2,324,000 | -43.3% | 10,462 | -45.0% | 0.16% | -26.7% |
| Q3 2020 | $4,096,000 | +114.5% | 19,018 | +76.1% | 0.22% | +30.7% |
| Q2 2020 | $1,910,000 | +540.9% | 10,802 | +402.2% | 0.17% | +213.2% |
| Q1 2020 | $298,000 | +44.0% | 2,151 | +50.1% | 0.05% | +17.8% |
| Q3 2019 | $207,000 | +430.8% | 1,433 | +125.3% | 0.04% | +181.2% |
| Q1 2013 | $39,000 | – | 636 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |